On August 6, 2020, the U.S. Department of Health and Human Services (HHS) announced that it will continue to expand access to pre-exposure prophylaxis (PrEP) HIV prevention medications at no cost to eligible individuals without prescription drug coverage. The expansion is through a $4 million contract with TrialCard for one year with four one-year option periods.
The contract is intended to support Ready, Set, PrEP, a key component of the “Ending the HIV Epidemic: A Plan for America” (EHE) initiative. EHE aims to reduce the number of new HIV infections in the United States by 75% by 2025 and by 90% by 2030. Ready, Set, PrEP makes PrEP available to uninsured people who have a prescription for the medication.
Ready, Set, PrEP was launched in December 2019, after HHS secured a donation of PrEP medications from Gilead Sciences Inc, the manufacturer of the two approved PrEP medications in the United States. Albertsons Companies, Avita Pharmacy, CVS Health, Health Mart, Rite Aid, Walgreens, and Walmart have donated medication dispensing services to HHS in support of the Ready, Set, PrEP program.
TrialCard Incorporated provides consumer affordability, medication access and adherence, consumer support, and clinical trial services on behalf of pharmaceutical manufacturers. Founded in 2000, TrialCard has connected nearly 33 million consumers with over $15 billion in branded drug savings to date.
This was reported by HHS on August 6, 2020, and by TrialCard on August 10, 2020.
Contact information: Michael Carlin, Vice President Marketing, TrialCard Incorporated, 2250 Perimeter Park Drive #300, Morrisville, North Carolina 27560; 919-415-3105; Email: email@example.com; Website: https://corp.trialcard.com/.